Tag: APAC Biotech

APAC Biotech’s Immuno-oncology drug Apceden gets approved in India

pharmanewsdaily- April 16, 2017

The Indian FDA (CDSCO - Central Drugs Standard Control Organization) has granted a commercial license to APAC Biotech to market Apceden, a Dendritic cell-based autologous ... Read More